Search results
Results from the WOW.Com Content Network
The Drug Rebate Equalization Act of 2009 (DRE), introduced in the 111th United States Congress by Representative Bart Stupak as H.R. 904, and in the Senate by Senator Jeff Bingaman as S. 547, sought to equalize the treatment of prescription drug discounts between Medicaid managed care and Medicaid fee-for-service.
The Texas Medication Algorithm Project (TMAP) [1] is a decision-tree medical algorithm, the design of which was based on the expert opinions of mental health specialists.It has provided and rolled out a set of psychiatric management guidelines for doctors treating certain mental disorders within Texas' publicly funded mental health care system, along with manuals relating to each of them The ...
By 1999, Texas’ Medicaid payments for antipsychotic drugs would soar, with Risperdal having the dominant market share. The state now paid $3,000 a year for each of its patients, compared to $250 a year for the generic first-generation drugs like Haldol.
Medicaid is the largest source of funding for medical and health-related services for people with low income in the United States, providing free health insurance to 85 million low-income and disabled people as of 2022; [3] in 2019, the program paid for half of all U.S. births. [4]
This is the list of Schedule III controlled substances in the United States as defined by the Controlled Substances Act at 21 U.S.C. § 812 (c) and 21 CFR 1308.13. The following findings are required for substances to be placed in this schedule: [1]
Medicare Part D spent a total of $4.6 billion on Ozempic in 2022, based on the most recent data we have from the Centers for Medicare & Medicaid Services. This spending covered 780,253 ...
Drug expenditures were $100.1 million in 2007 and $8.8 million in money spent on helping with insurance payments. This represented 344,600 prescriptions. [1] The total program budget is $1.4 Billion with California receiving $288 Million, New York $241 Million, Texas $101 Million, and Florida $97 Million. [2]
This is the list of Schedule II controlled substances in the United States as defined by the Controlled Substances Act. [1] The following findings are required for substances to be placed in this schedule: [2] The drug or other substance has a high potential for abuse. The drug or other substance has a currently accepted medical use in ...